AU2001267708A1 - Novel process for preparing crystalline particles - Google Patents

Novel process for preparing crystalline particles

Info

Publication number
AU2001267708A1
AU2001267708A1 AU2001267708A AU6770801A AU2001267708A1 AU 2001267708 A1 AU2001267708 A1 AU 2001267708A1 AU 2001267708 A AU2001267708 A AU 2001267708A AU 6770801 A AU6770801 A AU 6770801A AU 2001267708 A1 AU2001267708 A1 AU 2001267708A1
Authority
AU
Australia
Prior art keywords
novel process
crystalline particles
preparing crystalline
preparing
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267708A
Inventor
Robert William Lancaster
Hardev Singh
Andrew Lewis Theophilus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001267708A1 publication Critical patent/AU2001267708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/80Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
    • B01F31/85Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with a vibrating element inside the receptacle
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/45Magnetic mixers; Mixers with magnetically driven stirrers
    • B01F33/452Magnetic mixers; Mixers with magnetically driven stirrers using independent floating stirring elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80Mixing plants; Combinations of mixers
    • B01F33/82Combinations of dissimilar mixers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
AU2001267708A 2000-06-29 2001-06-29 Novel process for preparing crystalline particles Abandoned AU2001267708A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016002 2000-06-29
GBGB0016002.8A GB0016002D0 (en) 2000-06-29 2000-06-29 Novel process for preparing crystalline particles
PCT/GB2001/002936 WO2002000200A1 (en) 2000-06-29 2001-06-29 Novel process for preparing crystalline particles

Publications (1)

Publication Number Publication Date
AU2001267708A1 true AU2001267708A1 (en) 2002-01-08

Family

ID=9894695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267708A Abandoned AU2001267708A1 (en) 2000-06-29 2001-06-29 Novel process for preparing crystalline particles

Country Status (6)

Country Link
US (1) US20040091407A1 (en)
EP (1) EP1294362A1 (en)
JP (1) JP2004500985A (en)
AU (1) AU2001267708A1 (en)
GB (1) GB0016002D0 (en)
WO (1) WO2002000200A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596206B2 (en) 2001-03-30 2003-07-22 Picoliter Inc. Generation of pharmaceutical agent particles using focused acoustic energy
US6869551B2 (en) 2001-03-30 2005-03-22 Picoliter Inc. Precipitation of solid particles from droplets formed using focused acoustic energy
WO2003032951A1 (en) * 2001-08-29 2003-04-24 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
EP1585585B1 (en) * 2002-10-17 2012-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Process and reactor for the manufacture of powders of inhalable medicaments
US20040197275A1 (en) 2002-10-17 2004-10-07 Ecole Polytechnique Federale De Lausanne Process for the manufacture of powders of inhalable medicaments
BRPI0412029A (en) * 2003-06-30 2006-09-05 Alza Corp formulations for coated microprojections containing nonvolatile counterions
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
GB0504314D0 (en) * 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
WO2006096906A1 (en) * 2005-03-18 2006-09-21 Nanomaterials Technology Pte Ltd Inhalable drug
AU2006225066B2 (en) * 2005-03-18 2010-07-29 Nmt Pharmaceuticals Pte Ltd Inhalable drug
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
FR2897267A1 (en) * 2006-02-16 2007-08-17 Flamel Technologies Sa MULTIMICROPARTICULAR PHARMACEUTICAL FORMS FOR PER OS ADMINISTRATION
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7501406A (en) * 1975-02-06 1976-08-10 Dso Pharmachim Crystallisation of tetracycline hydrochloride - accelerated by subjecting to high-frequency vibrations, with purer, less toxic prod. formed
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9413202D0 (en) * 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9804000D0 (en) * 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
AU755470B2 (en) * 1999-01-29 2002-12-12 Bristol-Myers Squibb Company Sonic impinging jet crystallization apparatus and process
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof

Also Published As

Publication number Publication date
WO2002000200A1 (en) 2002-01-03
EP1294362A1 (en) 2003-03-26
GB0016002D0 (en) 2000-08-23
US20040091407A1 (en) 2004-05-13
JP2004500985A (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2001256732A1 (en) Process for producing crystal
AU2001241727A1 (en) Process for producing para-xylene
AU2002230470A1 (en) Process for preparing pouches
AU3994299A (en) Process for preparing 4-aminodiphenylamines
AU2001267708A1 (en) Novel process for preparing crystalline particles
AU2464401A (en) Process for the preparation of oligomeric compounds
AU2001227086A1 (en) Process for preparing 2-hydroxy-4-methylthiobutanoic acid
AU4363401A (en) Novel process for preparing (+)-cis-sertraline
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU5884700A (en) Process for making amine compounds
AU2001263046A1 (en) Process for preparing chitosan particles
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2229201A (en) Process for producing glycine
AU1149401A (en) Process for preparing jam
AU2001262226A1 (en) Process for the preparation of sterically hindered aryloxyamines
AU2001248825A1 (en) Process for producing microsphere
AU2001295934A1 (en) Process for producing substituted aniline compound
AU2001295934A2 (en) Process for producing substituted aniline compound
AU2001232158A1 (en) Crystallizing process
AU2002222604A1 (en) Process for preparing substance GM-95
AU6163000A (en) Process for producing polypropylene
AU2001289303A1 (en) Process for producing crystalline tagatose
AU3818900A (en) Process for the preparation of substituted piperidines
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001264385A1 (en) Novel cephalosporin compounds and process for preparing the same